When: Tuesday Oct 6th, 2015
Where: Polo Grill, 2038 Utica Square, Tulsa, Ok, 74114 - 918-744-4280
Topic: Xarelto (rivaroxaban) for reducing the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation and treatment of deep vein thrombosis and pulmonary embolism.
Speaker: David Sandler, MD; Oklahoma Heart Institute in Tulsa
Sponsor: Janssen Pharmaceuticals - Jason Day
Times: 5:00 pm - OACNS Board Meeting
6:00 pm Membership Meeting/ presentation approx 6:30pm
You must register online by Sept 29th